Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection
Canadian Medical Association Journal · 2023
DOI: 10.1503/cmaj.221570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Medical Association Journal, 2023. Verfasst von Marie Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Yan, Marras, Brode), University of Toronto, Toronto, Ont.; Clinician Investigator Program (Yan), University of British Columb…. Hauptthemen laut MEDLINE: Tuberculosis, Latent Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Tuberculin skin tests and IGRAs detect evidence of immunity to TB antigens but cannot distinguish TB infection from disease. Negative results do not exclude TB disease, as false negatives may occur for several reasons, including illness-induced anergy.[1][1] Therefore, TSTs and IGRAs should be
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Yan, Marras, Brode), University of Toronto, Toronto, Ont.; Clinician Investigator Program (Yan), University of British Columbia, Vancouver, BC; Departments of Medicine, and Global and Public Heal…
Zitieren
APA
Yan, M., Campbell, J. R., Marras, T. K., & Brode, S. K. (2023). Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.221570
Vancouver
Yan M, Campbell JR, Marras TK, Brode SK. Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection. Canadian Medical Association Journal. 2023. doi:10.1503/cmaj.221570
BibTeX
@article{Yan2023,
author = {Yan, Marie and Campbell, Jonathon R and Marras, Theodore K and Brode, Sarah K},
title = {Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection},
journal = {Canadian Medical Association Journal},
year = {2023},
doi = {10.1503/cmaj.221570}
}
EUVIMED